Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine Acetate for Migraine Prevention
NCT01820559Phase 2Completed
- Sponsor
- BIAL
- Start
- Apr 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eslicarbazepine acetate in migraine, sponsored by BIAL. Started Apr 2009; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01820559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01820559.